Buoyed by New Data, Galderma’s Liquid Toxin Launches Across Europe
Galderma is officially launching its ready-to-use liquid toxin relabotulinumtoxinA (Relfydess) in Europe. The launch took place at the IMCAS World Congress 2025 in Paris, France. RelabotulinumtoxinA is approved in 14 European countries for relaxing glabellar and canthal lines. It is the first neuromodulator to receive simultaneous approval for these two indications in Europe. The neuromodulator […]